AGL logo

agilon health (AGL)

Profile

Full Name

agilon health, inc.

Ticker Symbol

AGL

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 15, 2021

Indexes

Not included

Website

http://www.agilonhealth.com

Employees

1076

Key Details

Price

$3.22(-5.01%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.06B(+40.41% YoY)

Annual EPS

-$0.63(+1.56% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.22
    AGL price is $3.22

    30-Day Relative Volume

    0.90
    AGL 30-day relative volume is 0.90

    Price Performance

    Price Today change

    -5.01%
    AGL price is down -5.01% today

    Price YTD change

    +69.47%
    AGL price is up +69.47% since January 1st

    Price 1-year change

    -37.96%
    AGL price is down -37.96% year-on-year

    Price 3-year change

    -81.78%
    AGL price is down -81.78% over the past 3 years

    Price Range

    Price All-time high

    $44.83
    AGL price is currently -92.82% below its historical high of $44.83

    Price 3-year low

    $1.50
    AGL price is currently +114.67% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.33B
    AGL market capitalization is $1.33 billion

    Market cap 3-year change

    -81.45%
    AGL market capitalization is down -81.45% over the past 3 years

    Market cap All-time high

    $16.90B
    AGL market capitalization is currently -92.11% below its historical high of $16.90 billion

    Market cap sector rank

    78.71%
    AGL market capitalization is higher than 78.71% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.65%
    AGL shares outstanding is up +0.65% year-on-year

    Shares Outstanding 3-Year Change

    +1.78%
    AGL shares outstanding is up +1.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.09
    AGL beta is -0.09

    200-day SMA

    $3.58
    AGL price is currently -10.06% below its 200-day simple moving average

    50-day SMA

    $4.18
    AGL price is currently -22.94% below its 50-day simple moving average

    RSI

    36.89
    AGL 14-day relative strength index is 36.89

    Volume

    0.90
    AGL 30-day relative volume is 0.90

    ATR

    $0.49
    AGL average true range is $0.49

    10-day Historical Volatility

    159.20%
    AGL 10-day historical volatility is 159.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $6.06B
    AGL annual revenue is $6.06 billion

    Revenue Analysts estimate

    $5.94B
    AGL annual revenue is currently +1.95% higher than the consensus analysts' forecast

    Revenue 1-year change

    +40.41%
    AGL annual revenue is up +40.41% year-on-year

    Revenue Sector rank

    92.55%
    AGL annual revenue is higher than 92.55% of companies in Healthcare sector

    EPS

    EPS

    -$0.63
    AGL annual earnings per share is -$0.63

    EPS Analysts estimate

    -$0.30
    AGL annual earnings per share is currently +111.48% higher than the consensus analysts' forecast

    EPS 1-year change

    +1.56%
    AGL annual earnings per share is up +1.56% year-on-year

    EPS Sector rank

    64.23%
    AGL annual earnings per share is higher than 64.23% of companies in Healthcare sector

    Profit

    Gross profit

    $4.84M
    AGL annual gross profit is $4.84 million

    Gross margin

    0.08%
    AGL annual gross profit margin is 0.08%

    Operating profit

    -$288.53M
    AGL annual operating income is -$288.53 million

    Operating margin

    -4.76%
    AGL annual operating profit margin is -4.76%

    Net income

    -$260.15M
    AGL annual net profit is -$260.15 million

    Net margin

    -4.29%
    AGL annual net profit margin is -4.29%

    Expenses

    Total expenses

    $6.35B
    AGL annual total expenses is $6.35 billion

    Operating expenses

    $293.38M
    AGL annual total operating expenses is $293.38 million

    Cost of goods sold

    $6.06B
    AGL annual cost of goods sold is $6.06 billion

    Selling, general & administrative expenses

    $268.91M
    AGL annual SGA is $268.91 million

    Depreciation and amortization

    $24.46M
    AGL annual depreciation & amortization is $24.46 million

    Interest expense

    $6.18M
    AGL annual interest expense is $6.18 million

    Income tax

    $1.45M
    AGL annual income tax is $1.45 million

    EBIT & EBITDA

    EBIT

    -$242.65M
    AGL annual earnings before interest & taxes is -$242.65 million

    EBITDA

    -$218.19M
    AGL annual EBITDA is -$218.19 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.73B
    AGL annual total assets is $1.73 billion

    Non current assets

    $276.21M
    AGL annual long term assets is $276.21 million

    Current assets

    $1.46B
    AGL annual total current assets is $1.46 billion

    Cash and cash equivalents

    $188.23M
    AGL annual cash & cash equivalents is $188.23 million

    Accounts receivable

    $1.02B
    AGL annual accounts receivable is $1.02 billion

    Inventory

    -
    AGL annual inventory value is unknown

    Liabilities

    Total liabilities

    $1.26B
    AGL annual total liabilities is $1.26 billion

    Long term liabilities

    $111.03M
    AGL annual total long term liabilities is $111.03 million

    Current liabilities

    $1.15B
    AGL annual total current liabilities is $1.15 billion

    Accounts payable

    $1.15B
    AGL annual accounts payable is $1.15 billion

    Debt

    Total debt

    $41.50M
    AGL annual total debt is $41.50 million

    Total debt 1-year change

    -3.96%
    AGL annual total debt is down -3.96% year-on-year

    Long term debt

    $41.50M
    AGL annual long term debt is $41.50 million

    Short term debt

    -
    AGL annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $470.95M
    AGL annual stockholders equity is $470.95 million

    Book value

    $470.95M
    AGL annual book value is $470.95 million

    Retained earnings

    -$1.59B
    AGL annual retained earnings is -$1.59 billion

    Working capital

    $305.77M
    AGL annual working capital is $305.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$57.78M
    AGL annual cash flow from operations is -$57.78 million

    Cash from operations 1-year change

    +63.01%
    AGL annual cash flow from operations is up +63.01% year-on-year

    Cash from investing

    $139.89M
    AGL annual cash flow from investing activities is $139.89 million

    Cash from investing 1-year change

    +417.8%
    AGL annual cash flow from investing activities is up +417.8% year-on-year

    Cash from financing

    -$2.58M
    AGL annual cash flow from financing activities is -$2.58 million

    Cash from financing 1-year change

    +98.66%
    AGL annual cash flow from financing activities is up +98.66% year-on-year

    CAPEX

    CAPEX

    $41.28M
    AGL annual capital expenditures is $41.28 million

    CAPEX 1-year change

    +33.98%
    AGL annual capital expenditures is up +33.98% year-on-year

    Free Cash Flow

    Free cash flow

    -$99.06M
    AGL annual free cash flow is -$99.06 million

    Free cash flow 1-year change

    +47.03%
    AGL annual free cash flow is up +47.03% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    0.08%
    AGL annual gross profit margin is 0.08%

    Operating margin

    -4.76%
    AGL annual operating profit margin is -4.76%

    Net margin

    -4.29%
    AGL annual net profit margin is -4.29%

    ROA & ROE

    ROA

    -14.97%
    AGL annual return on assets is -14.97%

    ROE

    -45.96%
    AGL annual return on equity is -45.96%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AGL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AGL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.27
    AGL price to book ratio is 3.27

    PB ratio Sector rank

    73.14%
    AGL price to book ratio is higher than 73.14% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.22
    AGL price to sales ratio is 0.22

    PS ratio Sector rank

    7.36%
    AGL price to sales ratio is higher than 7.36% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.24B
    AGL enterprise value is $1.24 billion

    Enterprise value Sector rank

    76.94%
    AGL enterprise value is higher than 76.94% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.58
    AGL EV/EBITDA is -5.58

    EV/EBITDA Sector rank

    19.42%
    AGL EV/EBITDA is higher than 19.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.27
    AGL annual current ratio is 1.27

    Quick ratio

    -
    AGL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.07
    AGL annual debt to equity ratio is 0.07

    Interest coverage ratio

    -39.28
    AGL annual interest coverage ratio is -39.28

    Risk & Stability

    Piotroski F-Score

    3
    AGL piotroski f-score is 3

    Altman Z-Score

    2.60
    AGL altman z-score is 2.60

    Analyst ratings

    Recent major analysts updates

    Apr 28, 25 JMP Securities
    Market Perform
    Apr 25, 25 Citigroup
    Buy
    Apr 15, 25 TD Cowen
    Hold
    Apr 15, 25 Baird
    Neutral
    Apr 8, 25 Bernstein
    Outperform
    Mar 21, 25 Needham
    Hold
    Feb 26, 25 Stifel
    Hold
    Feb 26, 25 RBC Capital
    Outperform
    Feb 26, 25 Needham
    Hold
    Feb 26, 25 Citizens Capital Markets
    Market Perform

    Institutional Ownership

    Screeners with AGL included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Earnings this week
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for agilon health?
    • Does agilon health pay dividends?
    • What sector is agilon health in?
    • What industry is agilon health in?
    • What country is agilon health based in?
    • When did agilon health go public?
    • Is agilon health in the S&P 500?
    • Is agilon health in the NASDAQ 100?
    • Is agilon health in the Dow Jones?
    • When was agilon health's last earnings report?
    • When does agilon health report earnings?
    • Should I buy agilon health stock now?

    What is the ticker symbol for agilon health?

    The ticker symbol for agilon health is NYSE:AGL

    Does agilon health pay dividends?

    No, agilon health does not pay dividends

    What sector is agilon health in?

    agilon health is in the Healthcare sector

    What industry is agilon health in?

    agilon health is in the Medical Care Facilities industry

    What country is agilon health based in?

    agilon health is headquartered in United States

    When did agilon health go public?

    agilon health's initial public offering (IPO) was on April 15, 2021

    Is agilon health in the S&P 500?

    No, agilon health is not included in the S&P 500 index

    Is agilon health in the NASDAQ 100?

    No, agilon health is not included in the NASDAQ 100 index

    Is agilon health in the Dow Jones?

    No, agilon health is not included in the Dow Jones index

    When was agilon health's last earnings report?

    agilon health's most recent earnings report was on May 6, 2025

    When does agilon health report earnings?

    The next expected earnings date for agilon health is Aug 6, 2025

    Should I buy agilon health stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page